Αποτελέσματα Αναζήτησης
For pregnant women with acute VTE treated with LMWH, the ASH guideline panel suggests either once-per-day or twice-per-day dosing regimens.2,3 For pregnant women receiving therapeutic LMWH for the treatment of VTE, the ASH guideline panel suggests against routine monitoring of anti-FXa levels to guide dosing.4 Acute superficial vein thrombosis
10 Δεκ 2021 · For pregnant women with acute VTE treated with LMWH, the ASH guideline panel suggests either once-per-day or twice-per-day dosing regimens (conditional recommendation, very low certainty in evidence about effects). LMWH should be given in doses titrated against the woman's booking or early pregnancy weight.
24 Μαΐ 2023 · •All women should be aware that pregnancy and post-partum period increases the risk of thrombosis •Womenat high-risk of pregnancy-associated VTE should be counseled
27 Νοε 2018 · For pregnant women receiving therapeutic-dose LMWH for the treatment of VTE, the ASH guideline panel suggests against routine monitoring of anti-FXa levels to guide dosing (conditional recommendation, low certainty in evidence about effects ⊕⊕ ).
16 Ιαν 2016 · To address these questions, current guidelines from the American College of Obstetricians and Gynecologists (ACOG) [17, 18], the Society of Obstetricians and Gynaecologists of Canada (SOGC) [19], the Royal College of Obstetricians and Gynaecologists (RCOG) [20, 21], clinicians from Australia and New Zealand [22], and American College of Chest Ph...
6 Ιαν 2023 · The study also provides prospective data on the absolute risk of VTE in pregnancy for patients receiving anticoagulant prophylaxis. In summary, the authors are to be congratulated for establishing fixed low-dose LMWH as the standard prophylaxis regimen for pregnant women with prior VTE.
5 Οκτ 2023 · Introduction. Venous thromboembolism (VTE) in pregnancy is common. Pregnancy increases the relative risk of VTE six-fold compared to the background, non-pregnant population and complicates 1–2:1000 pregnancies.
